EBK HEALTH ECONOMICS AND POLICY
7th Edition
ISBN: 9781337668279
Author: Henderson
Publisher: YUZU
expand_more
expand_more
format_list_bulleted
Question
Chapter 4, Problem 3QAP
(a)
To determine
The total cost that must be borne by survivors and decedents of disease A.
(b)
To determine
The total cost that must be borne by survivors and decedents of disease B.
(c)
To determine
The expected cost of both diseases A and B.
(d)
To determine
The different costs and consequences of the two diseases using a decision tree.
(e)
To determine
The incremental costs and benefits of treatment options A and B.
(f)
To determine
The incremental cost effectiveness ratio.
Expert Solution & Answer
Trending nowThis is a popular solution!
Students have asked these similar questions
You have been recruited as an expert in health economics to recommend
what is the best therapy for a group of patients. In the image below you will
find the decision tree showing the probabilities for different health states
and outcomes for patients undergoing two possible treatments, No drug
therapy and Drug therapy. Based on the expected cost, which therapy
would you recommend as the least expensive? Explain how you arrived at
your recommendation and show your calculations the space provided.
No drug theraphy ?
Drug theraphy
?
HEALTH STATES
PROBABILITIES
Remain in Good Health
0.5
Develop disease A
0.2
Develop disease B
0.2
Die
0.1
Remain in Good Health
0.53
Develop disease A
0.16
Develop disease B
0.22
Die
0.09
OUTCOMES
(Costs)
$0
$400
$300
$200
SO
$800
$500
$0
In what sense is a cost-of-illness study a technique of economic evaluation? In what sense is it not? What is the primary motivation for doing a cost-of-illness study?
Consider two treatments. Treatment 1 saves one year of life at a cost of $10,000. Treatment 2 saves ten years of life at a cost of $1,000,000. Which treatment is more cost-effective? Why?
Chapter 4 Solutions
EBK HEALTH ECONOMICS AND POLICY
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, economics and related others by exploring similar questions and additional content below.Similar questions
- Which option is the most effective for companies and employees: a standard fee-for-services health care insurance option or a high-deductible health insurance plan.arrow_forwardHospital has the following treatment options to reduce the incidence of Ventilator-Associated Pneumonia: For Treatment X (status quo), it would cost 50,000 with 40 percent effectiveness, For Treatment Y, it would cost 100,000 with 85 percent effectiveness, For Treatment Z, it would cost 75,000 with 65 percent effectiveness, and For Treatment V, it would cost 80,000 with 68 percent effectiveness. Is there any treatment option that is not economically rational? Explain. If hospital’s willing to pay is $1000, which treatment option it would choose? Explain. With technical innovation, suppose Treatment V increased its effectiveness to 75 percent, would your answer to question (a) above change?arrow_forwardHospital has the following treatment options to reduce the incidence of Ventilator-Associated Pneumonia: For Treatment X (status quo), it would cost 50,000 with 40 percent effectiveness, For Treatment Y, it would cost 100,000 with 85 percent effectiveness, For Treatment Z, it would cost 75,000 with 65 percent effectiveness, and For Treatment V, it would cost 80,000 with 68 percent effectiveness. Is there any treatment option that is not economically rational? Explain. If the hospital’swilling to pay is $1000, which treatment optionwould it choose? Explain With technical innovation, suppose Treatment V increased its effectiveness to 75 percent, would your answer to question (a) above change?arrow_forward
- Which statement about health insurance in the US is false? Question options: 1) Going back to 1940, only about 10 percent of the US population had any health insurance 2) The share of the under-65 population with private health insurance rose until the 1970s and then plateaued—it remained virtually constant until the implementation of the Affordable Care Act 3) Early on, the health insurance market was dominated by Blue Cross plans, which practiced community rating in setting premiums 4) Measured in percentage points, the drop in the uninsured rate in the nonelderly population between 2013 and 2016 was larger than the increase in the share with private insurancearrow_forwardAssume that people receiving intervention A live 5 years at quality of life of 0.8 and people receiving intervention B live 10 years at quality of life of 0.4. Assume further that the two intervention have equal costs. Compare the cost-effectiveness of these interventions relative to each other and discuss how that would be altered by inclusion of future costs for younger adults and older adults.arrow_forwardFinkelstein, et al. (2003) estimate the national medical spending attributable to being overweight and obese to be $92.6 billion. This is an example of: Group of answer choices a. Cost-of-illness study b. Cost minimization c. Cost-effectiveness analysis d. Cost-benefit analysis e. None of the above.arrow_forward
- How do economic evaluations in Healthcare inform policy and other decision makersarrow_forwardHospital has the following treatment options to reduce the incidence of Ventilator-Associated Pneumonia: For Treatment X (status quo), it would cost 50,000 with 40 percent effectiveness, For Treatment Y, it would cost 100,000 with 85 percent effectiveness, For Treatment Z, it would cost 75,000 with 65 percent effectiveness, and For Treatment V, it would cost 80,000 with 68 percent effectiveness. a) Is there any treatment option that is not economically rational? Explain. b) If hospital’s willing to pay is $1000, which treatment option it would choose? Explain. c) With technical innovation, suppose Treatment V increased its effectiveness to 75 percent, would your answer to question (a) above change?arrow_forwardConsider two treatments. Treatment 1 saves one year of life at a cost of $10,000. Treatment 2 saves ten years of life at a cost of $1,000,000. Which treatment is more cost-effective? Why? Consider two treatments. Treatment 1 saves six years of quality adjusted life at a cost of $90,000. Treatment 2 saves three years of quality adjusted life at a cost of $60,000. Which treatment is preferred from a cost utility analysis perspective? Suppose Jay has been experiencing back pain and that there are two options for back pain: Treatment Regimen Total Cost Pain Reduction Do nothing $0 0 units Cortisone injections $600 30 units Calculate the ICER between cortisone injections and doing nothing. Jay says he is willing to pay $10 for a per unit of pain reduction. Should he choose cortisone injections? Another treatment is discovered. It costs $700 and reduces pain by 25 units. Should he choose the new treatment?arrow_forward
- Define the roles of the Chief Information Officer (CIO) and Chief Technology Officer (CTO) in health-care businesses. Make one (1) suggestion on how they can apply their knowledge to improve employee and patient satisfaction. Provide examples of such expertise in action to back up your claim.arrow_forwardAssume the following utility functions: U₁ = x2/3 and U₂ = x 1. What is the marginal utility of both utility functions? 2. Draw a graph showing the marginal utility of both functions in terms of number of contacts. Assuming that the marginal cost of a disease remains constant at 0.5, how many contacts would the two persons with utility functions U, and U, choose to have? Explain your answerarrow_forwardA person lives for 3 years with a disease and the current standard of care for that disease means he/she lives with a utility level of 0.7 . If that person takes a new medicine (Medicine A) because of which his/her utility level increases to 0.8, If another new medicine (Medicine B) prolongs the patient’s life by 2 years, at a utility level of 0.7,-Calculate the new QALYarrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
Decision Tree Analysis - Intro and Example with Expected Monetary Value; Author: Vincent Stevenson;https://www.youtube.com/watch?v=cbCsCQ4l4Zs;License: Standard Youtube License